Current studies have shown that in hepatocellular carcinoma (HCC), exosomal miR-210 secreted by HCC cells can be transferred to endothelial cells, thus promoting tumor angiogenesis by targeting SMAD4 and STAT6 (Lin X. J. et al., 2018). The gene discussed is SMAD4; the disease is hepatocellular carcinoma.